Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BrainsWay Ltd.

BWAYNASDAQ
Healthcare
Medical - Devices
$24.12
$0.00(0.00%)
U.S. Market opens in 16h 16m

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap487.3M
P/E Ratio73.24
EPS (TTM)$0.29
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$23.06
3 Months$24.86
1 Year Target$27.77

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 73.24 and a market capitalization of 487.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.50%
5-Day Change
-3.98%
1-Month Change
4.69%
3-Month Change
61.99%
6-Month Change
58.68%
Year-to-Date (YTD) Change
25.04%
1-Year Change
146.63%
3-Year Change
1203.78%
5-Year Change
175.66%
All-Time (Max) Change
117.49%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

1,200 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions